Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

Nucleic Acids Research

Volumn 40, Issue 15, 2012, Pages 7190-7206

  McDade, Simon S ^a   Henry, Alexandra E ^a   Pivato, Geraldine P ^a   Kozarewa, Iwanka ^b   Mitsopoulos, Constantinos ^b   Fenwick, Kerry ^b   Assiotis, Ioannis ^b   Hakas, Jarle ^b   Zvelebil, Marketa ^b   Orr, Nicholas ^b   Lord, Christopher J ^b   Patel, Daksha ^a   Ashworth, Alan ^b   McCance, Dennis J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN P63; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TRANSCRIPTION FACTOR AP 2GAMMA; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CLEFT PALATE; CONTROLLED STUDY; CULTURE TECHNIQUE; DNA DAMAGE; GENE; GENOME ANALYSIS; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; ORGANOTYPIC RAFT CULTURE; P63 TRANSCRIPTION FACTOR GENE; PRIORITY JOURNAL; TRANSCRIPTION FACTOR AP 2 ALPHA GENE; TRANSCRIPTION FACTOR AP 2 GAMMA GENE; TRANSCRIPTION REGULATION;

BINDING SITES; CELL DIFFERENTIATION; CELLS, CULTURED; CLEFT PALATE; EPIDERMIS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE ANNOTATION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84867305210     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks389     Document Type: Article

References (82)

1. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D. and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2, 305-316.
2. Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R. and Bradley, A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
3. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
4. Rinne, T., Brunner, H. G. and van Bokhoven, H. (2007) p63-associated disorders. Cell Cycle, 6, 262-268.
5. van Bokhoven, H. and Brunner, H. G. (2002) Splitting p63. Am. J. Hum. Genet., 71, 1-13.
6. McDade, S. S. and McCance, D. J. (2010) The role of p63 in epidermal morphogenesis and neoplasia. Biochem. Soc. Trans., 38, 223-228.
7. Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H., Van Bokhoven, H., McKeon, F. et al. (2002) A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol. Cell Biol., 22, 8601-8611.
8. Harmes, D. C., Bresnick, E., Lubin, E. A., Watson, J. K., Heim, K. E., Curtin, J. C., Suskind, A. M., Lamb, J. and DiRenzo, J. (2003) Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes. Oncogene, 22, 7607-7616.
9. Schavolt, K. L. and Pietenpol, J. A. (2007) p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Oncogene, 26, 6125-6132.
10. McDade, S. S., Patel, D. and McCance, D. J. (2011) p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels. J. Cell Sci., 124, 1635-1643.
11. Beretta, C., Chiarelli, A., Testoni, B., Mantovani, R. and Guerrini, L. (2005) Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63. Cell Cycle, 4, 1625-1631.
12. Ihrie, R. A., Marques, M. R., Nguyen, B. T., Horner, J. S., Papazoglu, C., Bronson, R. T., Mills, A. A. and Attardi, L. D. (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell, 120, 843-856.
13. Candi, E., Rufini, A., Terrinoni, A., Dinsdale, D., Ranalli, M., Paradisi, A., De Laurenzi, V., Spagnoli, L. G., Catani, M. V., Ramadan, S. et al. (2006) Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ., 13, 1037-1047.
14. Candi, E., Terrinoni, A., Rufini, A., Chikh, A., Lena, A. M., Suzuki, Y., Sayan, B. S., Knight, R. A. and Melino, G. (2006) p63 is upstream of IKK alpha in epidermal development. J. Cell Sci., 119, 4617-4622.
15. Nguyen, B. C., Lefort, K., Mandinova, A., Antonini, D., Devgan, V., Della Gatta, G., Koster, M. I., Zhang, Z., Wang, J., Tommasi di Vignano, A. et al. (2006) Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev., 20, 1028-1042.
16. Truong, A. B., Kretz, M., Ridky, T. W., Kimmel, R. and Khavari, P. A. (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev., 20, 3185-3197.
17. Flores, E. R. (2007) The roles of p63 in cancer. Cell Cycle, 6, 300-304.
18. Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V. et al. (2009) A mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell, 137, 87-98.
19. Muller, P. A., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P. et al. (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell, 139, 1327-1341.
20. Orso, F., Penna, E., Cimino, D., Astanina, E., Maione, F., Valdembri, D., Giraudo, E., Serini, G., Sismondi, P., De Bortoli, M. et al. (2008) AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J., 22, 2702-2714.
21. Badis, G., Berger, M. F., Philippakis, A. A., Talukder, S., Gehrke, A. R., Jaeger, S. A., Chan, E. T., Metzler, G., Vedenko, A., Chen, X. et al. (2009) Diversity and complexity in DNA recognition by transcription factors. Science, 324, 1720-1723.
22. Milunsky, J. M., Maher, T. A., Zhao, G., Roberts, A. E., Stalker, H. J., Zori, R. T., Burch, M. N., Clemens, M., Mulliken, J. B., Smith, R. et al. (2008) TFAP2A mutations result in branchio-oculo-facial syndrome. Am. J. Hum. Genet., 82, 1171-1177.
23. Park, P. J. (2009) ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet., 10, 669-680.
24. McCance, D. J., Kopan, R., Fuchs, E. and Laimins, L. A. (1988) Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Natl Acad. Sci. USA, 85, 7169-7173.
25. Goecks, J., Nekrutenko, A. and Taylor, J. (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol., 11, R86.
26. Blankenberg, D., Von Kuster, G., Coraor, N., Ananda, G., Lazarus, R., Mangan, M., Nekrutenko, A. and Taylor, J. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol., 10, 11-21.
27. You, F. M., Huo, N., Gu, Y. Q., Luo, M. C., Ma, Y., Hane, D., Lazo, G. R., Dvorak, J. and Anderson, O. D. (2008) BatchPrimer3: a high throughput web application for PCR and sequencing primer design. BMC Bioinformatics, 9, 253.
28. Li, H. and Durbin, R. (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25, 1754-1760.
29. Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, R137.
30. Robinson, J. T., Thorvaldsdottir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G. and Mesirov, J. P. (2011) Integrative genomics viewer. Nat. Biotechnol., 29, 24-26.
31. Blahnik, K. R., Dou, L., O'Geen, H., McPhillips, T., Xu, X., Cao, A. R., Iyengar, S., Nicolet, C. M., Ludascher, B., Korf, I. et al. (2010) Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res., 38, e13.
32. Schneider, T. D. and Stephens, R. M. (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res., 18, 6097-6100.
33. Ji, X., Li, W., Song, J., Wei, L. and Liu, X. S. (2006) CEAS: cis-regulatory element annotation system. Nucleic Acids Res., 34, W551-554.
34. Fujita, P. A., Rhead, B., Zweig, A. S., Hinrichs, A. S., Karolchik, D., Cline, M. S., Goldman, M., Barber, G. P., Clawson, H., Coelho, A. et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res., 39, D876-882.
35. Ye, T., Krebs, A. R., Choukrallah, M. A., Keime, C., Plewniak, F., Davidson, I. and Tora, L. (2011) seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res., 39, e35.
36. Edgar, R., Domrachev, M. and Lash, A. E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
37. Carroll, D. K., Carroll, J. S., Leong, C. O., Cheng, F., Brown, M., Mills, A. A., Brugge, J. S. and Ellisen, L. W. (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell Biol., 8, 551-561.
38. Della Gatta, G., Bansal, M., Ambesi-Impiombato, A., Antonini, D., Missero, C. and di Bernardo, D. (2008) Direct targets of the TRP63 transcription factor revealed by a combination of gene expression profiling and reverse engineering. Genome Res., 18, 939-948.
39. Pavlidis, P. and Noble, W. S. (2003) Matrix2png: a utility for visualizing matrix data. Bioinformatics, 19, 295-296.
40. Fury, W., Batliwalla, F., Gregersen, P. K. and Li, W. (2006) Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf. Proc. IEEE Eng. Med. Biol. Soc., 1, 5531-5534.
41. Lindsay, J., McDade, S. S., Pickard, A., McKloskey, K. and McCance, D. (2010) The potential role of p63-gamma isoforms in epithelial to mesenchymal transition. J. Biol. Chem., 286, 3915-3924.
42. Williams, T. and Tjian, R. (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev., 5, 670-682.
43. Westbrook, T. F., Nguyen, D. X., Thrash, B. R. and McCance, D. J. (2002) E7 abolishes raf-induced arrest via mislocalization of p21 (Cip1). Mol. Cell Biol., 22, 7041-7052.
44. McKenna, D. J., McDade, S. S., Patel, D. and McCance, D. J. (2008) MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J. Virol., 84, 10644-10652.
45. Westfall, M. D., Mays, D. J., Sniezek, J. C. and Pietenpol, J. A. (2003) The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell Biol., 23, 2264-2276.
46. Yang, A., Zhu, Z., Kapranov, P., McKeon, F., Church, G. M., Gingeras, T. R. and Struhl, K. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell, 24, 593-602.
47. Smeenk, L., van Heeringen, S. J., Koeppel, M., van Driel, M. A., Bartels, S. J., Akkers, R. C., Denissov, S., Stunnenberg, H. G. and Lohrum, M. (2008) Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res., 36, 3639-3654.
48. Consortium, E. P., Myers, R. M., Stamatoyannopoulos, J., Snyder, M., Dunham, I., Hardison, R. C., Bernstein, B. E., Gingeras, T. R., Kent, W. J., Birney, E. et al. (2011) A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol., 9, e1001046.
49. Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A. et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet, 39, 311-318.
50. Dennis, G. Jr, Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C. and Lempicki, R. A. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 4, P3.
51. Huang da, W., Sherman, B. T. and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
52. McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M. and Bejerano, G. (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol., 28, 495-501.
53. Smeenk, L., van Heeringen, S. J., Koeppel, M., Gilbert, B., Janssen-Megens, E., Stunnenberg, H. G. and Lohrum, M. (2011) Role of p53 serine 46 in p53 target gene regulation. PLoS One, 6, e17574.
54. Botcheva, K., McCorkle, S. R., McCombie, W. R., Dunn, J. J. and Anderson, C. W. (2011) Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle, 10, 4237-4249.
55. Becker, K. G., Barnes, K. C., Bright, T. J. and Wang, S. A. (2004) The genetic association database. Nat. Genet., 36, 431-432.
56. Dudas, M. and Kaartinen, V. (2005) Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. Curr. Top. Dev. Biol., 66, 65-133.
57. Blake, J. A., Bult, C. J., Kadin, J. A., Richardson, J. E. and Eppig, J. T. (2011) The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Res., 39, D842-D848.
58. Gritli-Linde, A. (2007) Molecular control of secondary palate development. Dev. Biol., 301, 309-326.
59. Passos-Bueno, M. R., Wilcox, W. R., Jabs, E. W., Sertie, A. L., Alonso, L. G. and Kitoh, H. (1999) Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat., 14, 115-125.
60. Riley, B. M. and Murray, J. C. (2007) Sequence evaluation of FGF and FGFR gene conserved non-coding elements in non-syndromic cleft lip and palate cases. Am. J. Med. Genet., 143 A, 3228-3234.
61. Suzuki, K., Hu, D., Bustos, T., Zlotogora, J., Richieri-Costa, A., Helms, J. A. and Spritz, R. A. (2000) Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat. Genet., 25, 427-430.
62. Sozen, M. A., Suzuki, K., Tolarova, M. M., Bustos, T., Fernandez Iglesias, J. E. and Spritz, R. A. (2001) Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat. Genet., 29, 141-142.
63. Kondo, S., Schutte, B. C., Richardson, R. J., Bjork, B. C., Knight, A. S., Watanabe, Y., Howard, E., de Lima, R. L., Daack-Hirsch, S., Sander, A. et al. (2002) Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat. Genet., 32, 285-289.
64. Moretti, F., Marinari, B., Lo Iacono, N., Botti, E., Giunta, A., Spallone, G., Garaffo, G., Vernersson-Lindahl, E., Merlo, G., Mills, A. A. et al. (2010) A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J. Clin. Invest., 120, 1570-1577.
65. Thomason, H. A., Zhou, H., Kouwenhoven, E. N., Dotto, G. P., Restivo, G., Nguyen, B. C., Little, H., Dixon, M. J., van Bokhoven, H. and Dixon, J. (2010) Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J. Clin. Invest., 120, 1561-1569.
66. Sharov, A. A. and Ko, M. S. (2009) Exhaustive search for over-represented DNA sequence motifs with CisFinder. DNA Res., 16, 261-273.
67. Oyama, N., Takahashi, H., Tojo, M., Iwatsuki, K., Iizuka, H., Nakamura, K., Homma, Y. and Kaneko, F. (2002) Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes. Arch. Dermatol. Res., 294, 273-280.
68. Williams, C. M., Scibetta, A. G., Friedrich, J. K., Canosa, M., Berlato, C., Moss, C. H. and Hurst, H. C. (2009) AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J., 28, 3591-3601.
69. Laurikkala, J., Mikkola, M. L., James, M., Tummers, M., Mills, A. A. and Thesleff, I. (2006) p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development, 133, 1553-1563.
70. Rodelsperger, C., Guo, G., Kolanczyk, M., Pletschacher, A., Kohler, S., Bauer, S., Schulz, M. H. and Robinson, P. N. (2011) Integrative analysis of genomic, functional and protein interaction data predicts long-range enhancer-target gene interactions. Nucleic Acids Res, 39, 2492-2502.
71. Kouwenhoven, E. N., van Heeringen, S. J., Tena, J. J., Oti, M., Dutilh, B. E., Alonso, M. E., de la Calle-Mustienes, E., Smeenk, L., Rinne, T., Parsaulian, L. et al. (2010) Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet., 6, e1001065.
72. Macquarrie, K. L., Fong, A. P., Morse, R. H. and Tapscott, S. J. (2011) Genome-wide transcription factor binding: beyond direct target regulation. Trends Genet., 27, 141-148.
73. Greene, R. M. and Pisano, M. M. (2010) Palate morphogenesis: current understanding and future directions. Birth Defects Res. C Embryo Today, 90, 133-154.
74. Dudas, M., Li, W. Y., Kim, J., Yang, A. and Kaartinen, V. (2007) Palatal fusion-where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem., 109, 1-14.
75. Eckert, D., Buhl, S., Weber, S., Jager, R. and Schorle, H. (2005) The AP-2 family of transcription factors. Genome Biol., 6, 246.
76. Rahimov, F., Marazita, M. L., Visel, A., Cooper, M. E., Hitchler, M. J., Rubini, M., Domann, F. E., Govil, M., Christensen, K., Bille, C. et al. (2008) Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat. Genet., 40, 1341-1347.
77. Gu, X., Coates, P. J., Boldrup, L. and Nylander, K. (2008) p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck. Cancer Lett., 263, 26-34.
78. Boldrup, L., Coates, P. J., Gu, X. and Nylander, K. (2009) DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target. J. Pathol., 218, 428-436.
79. Nottoli, T., Hagopian-Donaldson, S., Zhang, J., Perkins, A. and Williams, T. (1998) AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. Proc. Natl Acad. Sci. USA, 95, 13714-13719.
80. Wang, X., Pasolli, H. A., Williams, T. and Fuchs, E. (2008) AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. J. Cell Biol., 183, 37-48.
81. Wang, X., Bolotin, D., Chu, D. H., Polak, L., Williams, T. and Fuchs, E. (2006) AP-2alpha: a regulator of EGF receptor signaling and proliferation in skin epidermis. J. Cell Biol., 172, 409-421.
82. Guttormsen, J., Koster, M. I., Stevens, J. R., Roop, D. R., Williams, T. and Winger, Q. A. (2008) Disruption of epidermal specific gene expression and delayed skin development in AP-2 gamma mutant mice. Dev. Biol., 317, 187-195.